<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Review Articles Current State of Knowledge About SARS-CoV-2 and COVID-19" exact="Disease" post="in Pregnant Women GujskiMariusz1ABDEFHumeniukEwa2BDEFBojarIwona3ACDEF[1], [2], [3], Corresponding Author: Mariusz"/>
 <result pre="4.0 International (CC BY-NC-ND 4.0) Abstract During any epidemic of" exact="infectious diseases," post="pregnant women constitute an extremely sensitive group due to"/>
 <result pre="due to altered physiology and immune functions, and thus altered" exact="susceptibility to" post="infection. With regard to the management of pregnant COVID-19"/>
 <result pre="pregnant COVID-19 patients, in addition to the treatment of the" exact="infection" post="itself, which is not that different from generally accepted"/>
 <result pre="was to review the current state of knowledge about SARS-CoV-2" exact="infection" post="and COVID-19 disease in pregnant women. Because the epidemic"/>
 <result pre="the current state of knowledge about SARS-CoV-2 infection and COVID-19" exact="disease" post="in pregnant women. Because the epidemic began in China,"/>
 <result pre="in case of repeated epidemic emergencies. MeSH Keywords COVID-19 Parturition" exact="Pregnancy" post="Pregnancy Complications, Infectious Pregnancy Outcome SARS Virus The first"/>
 <result pre="case of repeated epidemic emergencies. MeSH Keywords COVID-19 Parturition Pregnancy" exact="Pregnancy" post="Complications, Infectious Pregnancy Outcome SARS Virus The first global"/>
 <result pre="repeated epidemic emergencies. MeSH Keywords COVID-19 Parturition Pregnancy Pregnancy Complications," exact="Infectious" post="Pregnancy Outcome SARS Virus The first global problem with"/>
 <result pre="epidemic emergencies. MeSH Keywords COVID-19 Parturition Pregnancy Pregnancy Complications, Infectious" exact="Pregnancy" post="Outcome SARS Virus The first global problem with viral"/>
 <result pre="Infectious Pregnancy Outcome SARS Virus The first global problem with" exact="viral" post="infections belonging to the Coronavirinae subfamily in the Coronaviridae"/>
 <result pre="Pregnancy Outcome SARS Virus The first global problem with viral" exact="infections" post="belonging to the Coronavirinae subfamily in the Coronaviridae family"/>
 <result pre="At present, the entire world is struggling with the SARS-CoV-2" exact="infection" post="pandemic. It has been observed that some types of"/>
 <result pre="and life appear periodically and unpredictably and spread rapidly. SARS-CoV-2" exact="infection" post="and COVID-19 disease were first identified in Wuhan, Hubei"/>
 <result pre="periodically and unpredictably and spread rapidly. SARS-CoV-2 infection and COVID-19" exact="disease" post="were first identified in Wuhan, Hubei province, China at"/>
 <result pre="was to review the current state of knowledge about SARS-CoV-2" exact="infection" post="and COVID-19 disease in pregnant women. Since the beginning"/>
 <result pre="the current state of knowledge about SARS-CoV-2 infection and COVID-19" exact="disease" post="in pregnant women. Since the beginning of the epidemic"/>
 <result pre="of available literature comes from studies conducted in that area." exact="Immunological" post="studies have led to a partial understanding of the"/>
 <result pre="conducted in that area. Immunological studies have led to a" exact="partial" post="understanding of the bodyâ€™s response to viral infections and"/>
 <result pre="led to a partial understanding of the bodyâ€™s response to" exact="viral" post="infections and the immune response to viruses. The immune"/>
 <result pre="to a partial understanding of the bodyâ€™s response to viral" exact="infections" post="and the immune response to viruses. The immune response"/>
 <result pre="Similar mechanisms of immune response occur during SARS-CoV-2 infection, causing" exact="pulmonary" post="and systemic inflammatory responses [4]. The viral inflammatory response"/>
 <result pre="of immune response occur during SARS-CoV-2 infection, causing pulmonary and" exact="systemic" post="inflammatory responses [4]. The viral inflammatory response plays a"/>
 <result pre="SARS-CoV-2 infection, causing pulmonary and systemic inflammatory responses [4]. The" exact="viral" post="inflammatory response plays a key role in cases of"/>
 <result pre="In the context of being at risk of further CoV" exact="infections" post="with high mortality rates, pregnant women seem to be"/>
 <result pre="rates, pregnant women seem to be in a special situation." exact="Pregnancy" post="is a period of far-reaching physiological adaptation of a"/>
 <result pre="as on one hand it must be ready to combat" exact="infections" post="and, on the other hand, it must tolerate antigenically"/>
 <result pre="pregnant womanâ€™s body are discussed in relation to further emerging" exact="infection" post="risks. The reaction of a pregnant womanâ€™s body to"/>
 <result pre="risks. The reaction of a pregnant womanâ€™s body to an" exact="infectious" post="agent may be slightly different. During the SARS and"/>
 <result pre="different. During the SARS and MERS epidemics, heavier courses of" exact="infections" post="and higher mortality rates were observed among pregnant women"/>
 <result pre="pandemic, there will be a more severe course of this" exact="infection" post="among pregnant women compared to non-pregnant ones. On the"/>
 <result pre="hormonal environment during pregnancy that affect the immune response to" exact="viral" post="pathogens, together with the physiological predominance of Th2, may"/>
 <result pre="the immune response associated with SARS-CoV-2. This may result in" exact="lower" post="intensity of COVID-19 symptoms in pregnant women compared to"/>
 <result pre="situation, when most countries are fighting the SARS-CoV-2 epidemic, even" exact="incomplete" post="data can be useful for planning the protection of"/>
 <result pre="pregnant COVID-19 patients, in addition to the treatment of the" exact="infection" post="itself, which is not that different from generally accepted"/>
 <result pre="the women have previously had concomitant diseases such as diabetes," exact="cardiovascular" post="diseases, or hypertension, single cases of infection have resulted"/>
 <result pre="such as diabetes, cardiovascular diseases, or hypertension, single cases of" exact="infection" post="have resulted in pregnancy hypertension and pre-eclampsia. The clinical"/>
 <result pre="or hypertension, single cases of infection have resulted in pregnancy" exact="hypertension" post="and pre-eclampsia. The clinical symptoms of COVID-19 were similar"/>
 <result pre="similar to those in other adults: fever (7/9), cough (4/9)," exact="muscle" post="pain (3/9), sore throat (2/9), malaise (2/9), gastrointestinal symptoms"/>
 <result pre="(1/9), and dyspnea (1/9). Laboratory tests showed elevated CRP (6/9)," exact="lymphopenia" post="(5/9), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) (3/9)."/>
 <result pre="assessed in 6 out of 9 cases in amniotic fluid," exact="breast" post="milk, umbilical cord blood culture, and newborn throat swab"/>
 <result pre="on the day of delivery, in the remaining ones after" exact="childbirth" post="(7 cesarean sections, 2 natural deliveries). Most of the"/>
 <result pre="be infected, 6 had dyspnea, 2 had fever, 2 had" exact="thrombocytopenia" post="with associated normal liver function, 1 had increased heart"/>
 <result pre="had thrombocytopenia with associated normal liver function, 1 had increased" exact="heart" post="rate, 1 had vomiting, and 1 had pneumothorax. One"/>
 <result pre="comparing the results of pregnant women infected with SARS-CoV-2 with" exact="pneumonia" post="(n=16) and 45 without pneumonia. Only 1 of the"/>
 <result pre="and 45 without pneumonia. Only 1 of the patients with" exact="pneumonia" post="had severe condition. The methods of delivery in both"/>
 <result pre="There was also no difference in intraoperative blood loss and" exact="neonatal" post="weight loss. None of the newborns had been infected."/>
 <result pre="5 patients (38%). There was a single case of stillbirth." exact="Premature" post="delivery with various indications occurred in 6 women (46%)."/>
 <result pre="pregnant women (both physicians) with COVID-19 in the third trimester." exact="Fever" post="(37.3~37.5Â°C) was found in a 34-year-old woman in the"/>
 <result pre="was confirmed 6 days after the beginning of the fever." exact="Pneumonia" post="was confirmed on day 8. A cesarean section was"/>
 <result pre="of life, the child developed fever and abdominal bloating with" exact="lymphopenia" post="(16.87%). On day 4, an X-ray of the thorax"/>
 <result pre="health problems. The symptoms started with a fever (37.6~38.5Â°C), nasal" exact="mucosa" post="congestion, and sore throat. The patient was admitted to"/>
 <result pre="after 2 days. The nasopharyngeal swab was positive for SARS-CoV-2." exact="Pneumonia" post="was diagnosed 5 days after the first symptoms appeared."/>
 <result pre="Although SARS-CoV-2 has not been detected, the newborn developed mild" exact="pneumonia" post="and lymphopenia (10.5%), with good response to treatment. The"/>
 <result pre="has not been detected, the newborn developed mild pneumonia and" exact="lymphopenia" post="(10.5%), with good response to treatment. The treatment of"/>
 <result pre="retrospective study [15] described 7 women aged 29â€&quot;34 years, with" exact="gestational" post="age from 37 to 41 weeks. Clinical symptoms included"/>
 <result pre="symptoms included fever (86%), as well as cough, dyspnea, and" exact="diarrhea" post="(14%). All patients had normal leukocyte count and elevated"/>
 <result pre="patients had normal leukocyte count and elevated C-reactive protein level." exact="Bilateral" post="pneumonia was present in 86% and 14% had unilateral"/>
 <result pre="had normal leukocyte count and elevated C-reactive protein level. Bilateral" exact="pneumonia" post="was present in 86% and 14% had unilateral pneumonia."/>
 <result pre="level. Bilateral pneumonia was present in 86% and 14% had" exact="unilateral" post="pneumonia. In 71%, neutrophil counts were higher than normal,"/>
 <result pre="neutrophil counts were higher than normal, and lymphocyte counts were" exact="lower" post="than normal. In total, 29% had various degrees of"/>
 <result pre="were lower than normal. In total, 29% had various degrees" exact="of liver" post="function abnormalities, low platelet count, and D-dimer level above"/>
 <result pre="In total, 29% had various degrees of liver function abnormalities," exact="low platelet count," post="and D-dimer level above normal. Antiviral treatment including oseltamivir"/>
 <result pre="to 27, 2020. Fourteen women (32.6%) did not have any" exact="viral" post="symptoms associated with COVID-19 at the time when SARS-CoV-2"/>
 <result pre="viral symptoms associated with COVID-19 at the time when SARS-CoV-2" exact="infection" post="was detected. Among them, 10 (71.4%) developed symptoms or"/>
 <result pre="Among them, 10 (71.4%) developed symptoms or signs of COVID-19" exact="infection" post="during or early after delivery. In 29 patients (67.4%)"/>
 <result pre="or early after delivery. In 29 patients (67.4%) who had" exact="symptomatic" post="COVID-19 infection, 3 women required hospitalization and antiviral treatment,"/>
 <result pre="summary, the authors stated that 37 (86%) women had a" exact="benign" post="form of COVID-19, 4 (9.3%) had serious disease, and"/>
 <result pre="4 (9.3%) had serious disease, and 2 (4.7%) developed critical" exact="disease" post="[16]. Studies published so far on pregnant women infected"/>
 <result pre="maternal virulence [19]. The suspicions that the course of SARS-CoV-2" exact="infection" post="and COVID-19 disease may be more severe in pregnant"/>
 <result pre="The suspicions that the course of SARS-CoV-2 infection and COVID-19" exact="disease" post="may be more severe in pregnant women compared to"/>
 <result pre="the immune system in pregnancy predispose to a more severe" exact="infection" post="course, as was the case during the SARS and"/>
 <result pre="was held, and strategies for the medical management of COVID-19" exact="infection" post="during pregnancy were discussed. The 10 most important recommendations"/>
 <result pre="basis. These recommendations concern the isolation, treatment, and monitoring of" exact="infections" post="in pregnant women. On the other hand, with still"/>
 <result pre="fetus [22]. In the future, the analysis of the COVID-19" exact="disease" post="among pregnant women will allow us to develop recommendations"/>
 <result pre="of repeated epidemic risk situations. Conclusions During any epidemic of" exact="infectious diseases," post="pregnant women constitute an extremely sensitive group due to"/>
 <result pre="due to altered physiology and immune functions, and thus altered" exact="susceptibility to" post="infection. In an epidemic situation, special care should be"/>
 <result pre="1HÃ¶rmansdorferSCampeHSingASARS â€&quot; pandemie und emerging diseaseJ Verbr Lebensm2008341720 2WerneryULauSWooPMiddle East" exact="respiratory" post="syndrome (MERS) coronavirus and dromedariesVet J2017220757928190501 3CucinottaDVanelliMWHO Declares COVID-19"/>
 <result pre="â€&quot; pandemie und emerging diseaseJ Verbr Lebensm2008341720 2WerneryULauSWooPMiddle East respiratory" exact="syndrome" post="(MERS) coronavirus and dromedariesVet J2017220757928190501 3CucinottaDVanelliMWHO Declares COVID-19 a"/>
 <result pre="dromedariesVet J2017220757928190501 3CucinottaDVanelliMWHO Declares COVID-19 a pandemicActa Biomed20209111576032191675 4LiGFanYLaiYet al.Coronavirus" exact="infections" post="and immune responsesJ Med Virol20209244243231981224 5ThevarajanINguyenTHOKoutsakosMet al.Breadth of concomitant"/>
 <result pre="in pregnancy and delivery: Rapid reviewUltrasound Obstet Gynecol20205555869232180292 8DashraathPWongLJLLimMXKet al.Coronavirus" exact="disease" post="2019 (COVID-19) pandemic and pregnancyAm J Obstet Gynecol2020[Epub ahead"/>
 <result pre="9ChenHGuoJWangCet al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: A retrospective review of medical"/>
 <result pre="ahead of print] 12LiuYChenHTangKet al.Clinical manifestations and outcome of SARS-CoV-2" exact="infection" post="during pregnancyJ Infect2020[Epub ahead of print] 13WangXZhouZZhangJet al.A case"/>
 <result pre="Dis2020[Epub ahead of print] 15YuNLiWKangQet al.Clinical features and obstetric and" exact="neonatal" post="outcomes of pregnant patients with COVID-19 in Wuhan, China:"/>
 <result pre="China: A retrospective, single-centre, descriptive studyLancet Infect Dis20202055596432220284 16BreslinNBaptisteCGyamfi-BannermanCet al.COVID-19" exact="infection" post="among asymptomatic and symptomatic pregnant women: Two weeks of"/>
 <result pre="descriptive studyLancet Infect Dis20202055596432220284 16BreslinNBaptisteCGyamfi-BannermanCet al.COVID-19 infection among asymptomatic and" exact="symptomatic" post="pregnant women: Two weeks of confirmed presentations to an"/>
 <result pre="their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus" exact="infections" post="and pregnancy outcomesArch Pathol Lab Med2020[Epub ahead of print]"/>
 <result pre="Dis20202055131432220285 20collab: Working Group for the Prevention and Control of" exact="Neonatal" post="2019-nCoV Infection in the Perinatal Period of the Editorial"/>
 <result pre="Working Group for the Prevention and Control of Neonatal 2019-nCoV" exact="Infection" post="in the Perinatal Period of the Editorial Committee of"/>
 <result pre="the Editorial Committee of Chinese Journal of Contemporary PediatricsPerinatal and" exact="neonatal" post="management plan for prevention and control of 2019 novel"/>
 <result pre="management plan for prevention and control of 2019 novel coronavirus" exact="infection" post="(1st Edition)Zhongguo Dang Dai Er Ke Za Zhi20202228790[in Chinese]32051071"/>
 <result pre="21ChenYLiZZhangYYet al.Maternal health care management during the outbreak of coronavirus" exact="disease" post="2019 (COVID-19)J Med Virol2020[Epub ahead of print] 22ChenDYangHCaoYet al.Expert"/>
</results>
